Drug Interaction Between Azithromycin and Risperidone

Mechanism of Interaction

The American College of Cardiology recognizes azithromycin as a definite cause of QT prolongation, serious arrhythmias, and increased risk for sudden death, with advanced age and female sex as particular risk factors 1, 2
Both azithromycin and risperidone independently prolong the QT interval through effects on cardiac ion channels, creating an additive risk when used together 1, 2
The combination can provoke torsades de pointes and non-pause-dependent polymorphic ventricular tachycardia 1, 2

The American College of Cardiology recommends avoiding the combination of azithromycin and risperidone in patients with a baseline QTc interval ≥ 500 ms 2
Patients with known congenital long-QT syndrome should avoid this combination 2
Concurrent use of other QT-prolonging medications increases the risk of cardiac arrhythmias 2
Uncorrected electrolyte abnormalities, such as hypokalemia or hypomagnesemia, increase the risk of QT prolongation 2, 5
Advanced age, particularly elderly females, is a risk factor for QT prolongation and cardiac arrhythmias 1, 2
Pre-existing cardiac conditions, including structural heart disease or bradycardia, increase the risk of cardiac arrhythmias 2
Hepatic or renal impairment may increase drug levels and associated risks 5

The American College of Cardiology recommends obtaining a baseline ECG to measure QTc interval before initiating combination therapy, and withholding both drugs if QTc ≥ 500 ms 2
Correcting electrolyte abnormalities, particularly potassium and magnesium, is essential before initiating combination therapy 2, 5
Reviewing all concurrent medications for additional QT-prolonging agents is crucial to minimize the risk of cardiac arrhythmias 2
Assessing hepatic and renal function is necessary to minimize the risk of increased drug levels and associated risks 5
Monitoring cardiac rhythm and repeating ECG at 4 hours and 24 hours after initiating combination therapy is recommended for high-risk patients 2
Discontinuing both medications immediately if QTc exceeds 500 ms is essential to prevent cardiac arrhythmias 2

The American College of Cardiology recommends considering alternative antibiotics without QT prolongation effects, such as amoxicillin or doxycycline, depending on the clinical indication 5
Verifying that azithromycin is truly necessary and following guidelines that recommend against routine antibiotic use without documented bacterial infection is essential 5

The American College of Cardiology warns against assuming safety based on lack of metabolic interaction alone, as the cardiac risk is pharmacodynamic and independent of CYP450 interactions 2
Overlooking concurrent medications that may also prolong QT interval creates cumulative risk 2
Skipping baseline ECG in high-risk patients is not recommended, as it is essential for safe monitoring 2
Ignoring electrolyte disturbances, such as hypokalemia and hypomagnesemia, significantly exacerbates QT prolongation risk 2, 5